Clusterin is not essential for androgen-regulated involution and regeneration of the normal mouse prostate

Dieter Fink1, Ladan Fazli, Bruce Aronow

  • 1The Prostate Centre at VGH, University of British Columbia, Vancouver, British Columbia, Canada.

The Prostate
|July 26, 2006
PubMed
Abstract

Insights

Clusterin is not essential for normal prostate gland regeneration after androgen withdrawal. This finding suggests clusterin may have different roles in prostate cancer versus healthy prostate cells.

Area of Science:

  • Urology
  • Molecular Biology
  • Oncology

Background:

  • Clusterin inhibition improves prostate cancer treatment sensitivity.
  • Clusterin antisense oligonucleotides (ASOs) are in clinical trials for prostate cancer.
  • The role of clusterin in normal prostate involution and regeneration is unknown.

Purpose of the Study:

  • To investigate the role of clusterin in androgen-regulated prostate involution and regeneration.
  • To determine if clusterin is critical for normal prostate gland function.

Main Methods:

  • Examined prostate involution and regeneration in clusterin-deficient mice.
  • Utilized multiple cycles of androgen withdrawal and restoration.

Main Results:

  • Clusterin deficiency did not impact the apoptotic index during prostate involution and regeneration.
  • Biochemical and morphological changes were unaffected by clusterin deficiency.

Conclusions:

  • Clusterin is not critical for normal prostate development or androgen-regulated regeneration in mice.
  • Clusterin may have distinct functions in malignant versus normal prostate epithelial cells.

Related Concept Videos